chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BLOODY MUCOUS WHEN BLOWING NOSE/BLOODY SNOT ON NOSE; GENERALIZED ANXIETY DISORDER / ANXIETY SPIRAL (HEAVY BREATHING, COULD NOT SLEEP); LOOKED LIKE BRUISE ON LEG; PAIN IN ARM/ARM STARTED TO HURT BADLY IN THE AREA ABOUT THE SIZE OF A PALM; This spontaneous report received from a patient concerned a 37 year old female. The patient's weight was 256 pounds, and height was 67 inches. The patient's concurrent conditions included very rare alcohol use, and non-smoker, and other pre-existing medical conditions included patient had no past medical history. the patient had no history of drug abuse or illicit drug use. The patient experienced drug allergy when treated with metoclopramide hydrochloride.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-MAY-2021, the subject experienced pain in arm/arm started to hurt badly in the area about the size of a palm. On 29-MAY-2021, the subject experienced generalized anxiety disorder / anxiety spiral (heavy breathing, could not sleep). On 29-MAY-2021, the subject experienced looked like bruise on leg. On JUN-2021, the subject experienced bloody mucous when blowing nose/bloody snot on nose. Treatment medications (dates unspecified) included: escitalopram oxalate. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bloody mucous when blowing nose/bloody snot on nose on 21-JUL-2021, and pain in arm/arm started to hurt badly in the area about the size of a palm on 09-JUN-2021, had not recovered from generalized anxiety disorder / anxiety spiral (heavy breathing, could not sleep), and the outcome of looked like bruise on leg was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment Comment not required as per standard procedure as case assessed as non-serious.
Headache for about 12 hours; extreme fatigue such that hard to work , needed to take breaks to alt down; extreme muscle soreness particularly in legs and arms . Hard to walk   Lasted for entire day after shot. When I woke up next day, was totally fine. So lasted about 36 hours.
Pt reports that approx 2-3 days after receiving the 2nd Covid vaccine, her left upper arm became sore and she had difficulty lifting her shoulder due to decrease ROM, pain, and stiffness.  The vaccine was given on 4/13/21.  She did not take any OTC medications. Did not try any ice or heat to alleviate the pain.  Presented to PCP on 5/27/21 due to continued soreness. Ibuprofen prescribed. Heat or ice. X-rays ordered.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. Patient's pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On 28-APR-2016, the patient was vaccinated with an expired dose of (Oka/Merck) VARIVAX in error (expiration date 11-APR-2016) (dosing details, anatomical location and lot# unknown). No known adverse effects were reported. Additional information has been requested.
Fever - 103 degrees and tired; Fever - 103 degrees and tired; This is a spontaneous report from a contactable consumer (patient). A 12-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0168), intramuscular in left arm on 17May2021 15:00 (at the age of 12-years-old) as first dose, single for COVID-19 immunization. Medical history was none. The patient had no known allergies. Concomitant medication included fexofenadine hydrochloride (ALLEGRA). Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks prior. The patient experienced fever - 103 degrees and tired on 18May2021 12:00. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of the event was unknown.
7/6/06: R knee pain and swelling (relief with ibuprofen and ice after 2 days) 7/11/06: R 3rd finger pain, joint swelling and numbness (relief with ibuprofen & ice after 3 days) 7/15/06: L wrist pain, swelling and tingling 7/16/06: visit to clinic due to discomfort and referral to PCP (scheduled for 7/18/06)
Post Vaccine Myocarditis with chest pain 1 day post vaccine, hospitalized in PICU and monitored.
TRUMENBA was given as an alternative to MENACTRA. No adverse reaction reported to facility.
Left arm went numb at work 3 days after vaccination. 2 days later I was diagnosed with GBS and all 4 extremities, tongue, lips and esophagus were numb I was unable to use arms or legs. Now beginning to learn to walk with a walker. Experience very low endurance. Use 4-leg cane to go up and down stairs.
Fatigue, headache, chills, sweats and nausea beginning the day after vaccination 12/29. Symptoms constant, but intermittently waxing and waning in intensity. Did limit normal activities. Reported check ins.  Currently day 5 of a symptoms and was sent home from work today.
Colitis ulcerative aggravated; This is a Solicited report based on the information received by Pfizer from a company (Manufacturer Control No: 21K-163-4052522-00). A contactable  consumer (patient) reported a 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 on 01Mar2021, dose 2 on 23Mar2021, both via intramuscular (at age of 59-year-old) at single dose for COVID-19 immunisation; adalimumab (HUMIRA), subcutaneously from an unspecified date, at unspecified dose for moderate to severe ulcerative colitis. The patient's medical history and concomitant medications were not reported.  The patient experienced colitis ulcerative aggravated on an unspecified date in 2021. The event was reported as non-serious ulcerative colitis flare after COVID vaccine with adalimumab. It was unknown if patient was enrolled in a Covid-19 Vaccine Trial. The action taken in response to the event for adalimumab was unknown. The outcome of the event was unknown. The reporter's causality for the event of ulcerative colitis flare after COVID vaccine with adalimumab was not provided. The reporter's causality for the event of ulcerative colitis flare was possible related to bnt162b2.   No follow up attempts are possible; Information about lot/batch number cannot be requested. No further information is expected.; Sender's Comments: Based on the information in the case report, a possible causal relationship between the event colitis ulcerative and suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Intense headache, at 10pm dizziness, headache, malaise, body aches, 1am temp 102F, chills, nausea, vomit x1 at 5am.
his blood test revealed that the "PSA" value was reduced by 40 percent after getting MODERNA COVID 19 vaccine; no adverse event; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (his blood test revealed that the "PSA" value was reduced by 40 percent after getting MODERNA COVID 19 vaccine) and NO ADVERSE EVENT (no adverse event) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (his blood test revealed that the "PSA" value was reduced by 40 percent after getting MODERNA COVID 19 vaccine) and NO ADVERSE EVENT (no adverse event). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (his blood test revealed that the "PSA" value was reduced by 40 percent after getting MODERNA COVID 19 vaccine) and NO ADVERSE EVENT (no adverse event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Prostatic specific antigen: reduced by 40 percent.         No concomitant medications were reported.   It was reported that, the patient's blood test revealed that the prostatic specific antigen (PSA) value was reduced by 40 percent after vaccination. The patient had requested additional injections, now that the Bi-valent formula was in use, and they noticed PSA leveled out.  According to the patient the mRNA vaccines, specifically the original Moderna formulation might be effective in controlling or combating prostate cancer.  No treatment details were reported.
Tremors; Body aches; Sore arm with quarter size bruise at injection site; Sore arm with quarter size bruise at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 69-year-old non-pregnant female patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the left arm on 30Sep2021 at 10:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to alpha-gal allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685) via an unspecified route of administration on 15Jan2021 (at the age of 68-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3246) via an unspecified route of administration on 05Feb2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 30Sep2021 at 18:30, the patient experienced tremors, body aches, sore arm with quarter size bruise at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tremors, body aches, sore arm with quarter size bruise at injection site was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Febrile seizure developed on 10-25 -> to hospital  - 2nd episode of seizure , fever to 104, was admitted x 3 days.
I saw him in the office on June 22, 2021. He informed me that 2 weeks after his 2nd COVID-19 vaccine dose, he started losing his hair (Symptoms began around March 5th, 2021). Patient presented to my office with 10-15% hair loss in circular discrete patches in his scalp and beard areas. I preformed a punch biopsy of the scalp, which resulted back as Alopecia Areata. The patient was informed of his biopsy results at his suture removal appointment (July 5th, 20201) and he started topical treatments for hair regrowth, and will return in 6 weeks for an injection into his scalp.
My cousin's granddaughter developed Autism after being given thimerosol early heavy vaccines, she and the mom were working in a doctor's office at the time.
Hair thinning; Pain; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair thinning) and PAIN (Pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced ALOPECIA (Hair thinning) and PAIN (Pain). At the time of the report, ALOPECIA (Hair thinning) had not resolved and PAIN (Pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 23-Nov-2021: Updated event tab and added vaccine details.
Symptom onset difficulty passing solids, then fluids, into the stomach. Endoscopic then ultrasound and biopsy confirmed neoplasm, probably adenocarcinoma of the esophagus or surrounding structure.
Vomiting after 30min after he arrived at school after receiving varicella the previous day and was well. Complained of difficulty walking with arthralgia and myalgia. No soreness, redness or lesions anywhere.
Broke out with severe urticartia/hives over entire body the same night as vaccine. The hives have lasted the past 3 weeks and arent getting any better. I am being treated with antihistimines/prednizone/lotion daily.
Patient complained of heavy feeling in chest.  Weak thready pulse, BP 126/85, P 98.  Was given crackers and water and said she felt much better.
Pt, approximately 25 minute safter vaccination, developed urticaria, shortness of breath, and complaint of tightness in her throat.  Pt assessment showed patent airway with rhonchi for which she was given .3mg Epinephrine IM and 50 mg Diphenhydramine for urticaria.  Pt recieved no further medication and was transported via emergency services.
March 21 I had fever 101 , fatigue, nausea, body aches, headache that kept me from my daily functions. Reporting app did not ask about that date and I want to report that was a bad day. I did not seek medical treatment. Treated with ibuprofen and rest
Myalgia, Fever, NauseaVomiting,  Stomachache Narrative:
has had a fever since 10 hours after and still has a fever and headache, also had a splitting HA 103 fever swallon limp nodes night sweats very dry mouth
Ringing in my ear in the right ear for 8 hrs. 1september2021 I saw the doctor.
Client did not experience an adverse event upon receiving the vaccine on 1/9/18; client's parent informed immunization nurse at appointment for MMR/VZV Dose #2 that client was pregnant and was due July 2018. Client nor family knew of the pregnancy until 2/5/18 when UCG was resulted positive and therefore did not know of pregnancy when MMR/VZV Dose #1 was administered on 1/9/18. This VAER is for information purposes, as client has not experienced an adverse event to date.
Nausea,chills,  fever of 102 with extreme body aches & migraine. Very sore & bruised arm at the injection site.
I was completely healthy prior to the vaccine. Less than 2 weeks after receiving the vaccine, I had an attack involving chest pain, extreme headache, dizziness, shortness of breath so severe I went to the emergency room. After multiple tests, they could only diagnose me with sudden onset hypertension. I went on to have multiple episodes same as the first day of this attack for months. After months of chest palpitations, dizziness, loss of vision, shortness of breath, monitoring found cardiac arrhythmia and have received a pacemaker. I believe the vaccine impacted my heart and led to the arrhythmia situation.
Inj 10/06/2005 48 hours past right deltoid injection site developed slight pain, then paresthesia over arm to hand, tingling, electric shock like sensation of weakness. On 10/27 still intermittent tingling.
D-dimer was elevated to 14,368 which indicated a CTA of the chest showing bilateral lower lobe segmental and subsegmental pulmonary emboli with moderate overall clot burden and no evidence of right heart strain, and mild bibasilar atelectasis.  The patient is on a heparin drip and is admitted to the hospital.
Blistering rash on bilateral legs, abd, and back - mild.  No documented fever, no SOB, no other symptoms.  Recommended to do OTC anti-histamines for itching.
On May 3rd, I got up from dinner. I was staggering from room to room and was feeling indigestion, so I sat down and later went to bed. The next morning, I woke up and exercised as well as taking a 4 mile walk and then had another episode of staggering and indigestion. At the encouragement of my family, I went to the local hospital where they did a cat scan and EKG and blood work. I was seen by a cardiologist and a neurologist. They were thinking of releasing me but that night I woke up and sat up but felt very dizzy and requested to stay longer. I also have tinnitus in one ear and use a hearing aide so they brought in an ENT doctor who said that there is a possibility of Meniere's disease. The doctors did not suspect a heart attack or stroke and were not concerned about my heart, so they released me on the 6th. They did change my blood pressure medication when I was hospitalized due to my blood pressure being too low. I have not been feeling quite well since then and have been having issues in my neck. I have experienced neck issues in the past due to a car accident, but it has been worse than normal.
15jan90 pt vax hepta B. devel. rash & itching. pt seen in emerg. room on 17jan90 w/ severe itching,rash,cough. treated w/ benadryl. 1 day later ex. malaise,nausea,aching joints.  Physician thought urticaria was due to vax.
This spontaneous report was received from a medical assistance and refers to a patient of unknown demographics. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On approximately 23-NOV-2015 (reported as "on either 23-NOV-2015 or 24-NOV-2015"), the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) lot # reported as L019998, expiration date: 02-DEC-2016 (dose and route were not provided). No symptoms were reported. Additional information has been requested.
Patient reported that he got severe shingles breakouts four days after second dose of SHINGRIX vaccine. Patient went to see medical assistance and was prescribed Valacyclovir 500 to help recover from Shingles.
Vaccine administered Thursday, 4/1 1:15 p.m. By Sunday I experienced mild headache and upper respiratory scratchiness. By late Monday 4/5 I experienced fatigue, dizziness, upper respiratory scratchiness and increased post-nasal drip, tightness in my chest, muscle soreness and headache. By Tuesday, 4/6 around 10 a.m. in addition to the above symptoms I had a severe headache and lost feeling in my right arm for half an hour, with severe muscle cramps and loss of use in that arm. The muscle issues subsided by early afternoon leaving only fatigue, headache, dizziness and a lingering respiratory tightness and sinus issues. Concerned about vaccine side-effects I was reading about, I made a doctor's appointment for the following week (earliest available), met with a physician's assistant who prescribed an antibiotic (Doxycycline Mono 100 Mg) for the sinus issues but did not address the other issues.
Severe cough. Doctors ruled it likely a side effect of the Jansen vaccine, and also decided that combined with Meloxicam, a medication that promotes bleeding, led to a torn flank and internal bleeding. Hospitalized for 2 days. Rehab ongoing.
Received second Pfizer COVID-19 vaccine on 4/28/21 and awakend with Bell's Palsy on 4/29/21. We treated with prednisone, valcyclovir and eye drops.
developed stroke with generalized body weakness, unable to speak or respond to command. Continues at this time with weakness/inability speak/feed for herself.
Had abdominal pain, headache, loss of appetite, still feels like upper respiratory illness, difficulty breathing; feel cold.
The pt received the vaccines on 4/13/01 and on 4/22/01 woke from nap with rash on cheeks, stomach and bottom. Mother consulted physician and felt like it was probably due to MMR vaccine.
Patient reported not feeling well at 3:50pm.  Stated she was lightheaded and nauseous. Informed patient to stay for further evaluation and monitoring. At 4:15pm, patient vomited x1 with continued nausea and feeling lightheaded. RRT was called at this time. RRT arrived at 4:20pm to assess patient when patient stated she was no longer lightheaded or nauseous. At 4:35pm patient was taken to ER for further evaluation.  Vital signs at 3:50pm: BP 107/59, HR 74, SPO2 96%. Vital signs at 4:05pm: BP 110/52, HR 72, SPO2 96%. Vital signs at 4:20pm: BP 131/82, HR 82, SPO2 95%. Patient was discharged same day on 02/17/21.  Follow up today 02/18/21: Patient stated she was feeling better as time goes by. States her only symptom now is an upset stomach. No other side effects noted.
The injection was painful going in. No other symptoms on the day-of. The following day, the injection sight was painful to the touch. I had body and muscle aches in my full body including neck, back, abdomen area, legs, and arms. I had a headache most of the day. I had the chills throughout the full day and had on and off nausea. I was extremely tired and stayed in bed almost all day. 2 days after the vaccine, all of these symptoms were gone except the injection sight is still slightly tender 4 days later.
Inflammation in right shoulder where humoral and biceps ligaments/tendons articulate. Pain, constant, now chronic muscle cramping and weakness. Same happened in left arm after booster dose in Nov. 2021. Both injections were very painful and have resulted in now chronic pain and weakness that are limiting my strengths and range of motion.
SLIGHT HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine (series 1) for prophylactic vaccination (manufacturer unspecified).  The patient received company booster covid-19 vaccine ad26.cov2.s  (series 2) (suspension for injection, route of admin not reported, batch number and expiry: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s the patient experienced slight headache and felt great by the evening. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight headache. This report was non-serious. This case, from the same reporter is linked to 20211150219.
Developed rash (red, raised, warm, itchy) on left arm in area where shot was received.  Symptoms developed 1 week after shot was received.  Treating with anti-itch cream and icing arm.
13 hours - joint pain, body aches, chills, slight fever, headache, brain fog, pain 7/10 at injection site all that day long  - platooned tylenol and advil lymph nodes on right of chest and right armpit sore next day - chills, fever,  headache brain fog mostly resolved; injection site pain down to 4/10; lymph node in right collar bone area is now greatly enlarged (size of a small egg ) and very sore.  third day - joint pain and body aches mostly resolved; injection site pain down to 2/10;  enlarged lymph node in collar bone are still present and sore; additional red, warm, sore "knot" developed about an inch lower and to the side of injection site  fourth day (today) - lymph node still enlarged but less sore; knot on arm under injection site still present and sore